TD Waterhouse Canada’s Purple Biotech PPBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20
Closed -$938 2042
2024
Q4
$938 Hold
20
﹤0.01% 1791
2024
Q3
$1.14K Hold
20
﹤0.01% 1693
2024
Q2
$1.44K Hold
20
﹤0.01% 1694
2024
Q1
$3.63K Hold
20
﹤0.01% 1589
2023
Q4
$4.22K Hold
20
﹤0.01% 1403
2023
Q3
$6.02K Hold
20
﹤0.01% 1322
2023
Q2
$7.37K Hold
20
﹤0.01% 1310
2023
Q1
$9.58K Buy
+20
New +$7.5K ﹤0.01% 1233

Other funds holding PPBT

TD Waterhouse Canada's PPBT Position: Q1 2025 in Review

TD Waterhouse Canada sold out of Purple Biotech (PPBT) in Q1 2025, closing a stake of 20 shares — an estimated $938 sold.

TD Waterhouse Canada first reported a position in PPBT in Q1 2023 and held it in 8 quarters. The position peaked at $9.58K in Q1 2023. 9 funds tracked by Wall St. Rank hold PPBT as of Q1 2025.

  • TD Waterhouse Canada reported no remaining Purple Biotech position as of Q1 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 20 Purple Biotech shares in Q1 2025, an estimated $938.
  • TD Waterhouse Canada first reported a position in Purple Biotech in Q1 2023 and held it in 8 quarters.
  • TD Waterhouse Canada's Purple Biotech position peaked at $9.58K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2025.

Based on TD Waterhouse Canada's 13F filing for Q1 2025, filed 9 May 2025.